$289.57+3.28 (+1.15%)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States.
The Cigna Group in the Healthcare sector is trading at $289.57 with a market capitalization of $76.1B. Wall Street consensus targets $340.92 (24 analysts), implying a +17.7% move over the next 12 months. The stock is currently 8% below its 52-week high of $315.47, remaining 4.2% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $68.29Bβ | $72.13Bβ | $69.52Bβ | $66.94Bβ | $65.26B |
| Gross Profit | $6.27Bβ | $6.08Bβ | $6.14Bβ | $5.92Bβ | $6.37B |
| Operating Income | $2.16Bβ | $2.01Bβ | $2.35Bβ | $2.07Bβ | $1.73B |
| Net Income | $1.65Bβ | $1.23Bβ | $1.87Bβ | $1.53Bβ | $1.32B |
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includ...
The healthcare giant looks expensive on today's numbers, but a patient investor is effectively buying it at a significant discount to that price.
A company that generates cash isnβt automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Investors are rightly focused on the company's Medicaid struggles, but the real upside story may be hiding in plain sight across the rest of its business.
UnitedHealth's stock is flying high after it raised guidance, but on its latest earnings call, analysts zeroed in on an underlying margin divergence running right through the business.
The stock is trading near 52-week highs, but under the surface, commercial segment cost trends are creating headwinds.